KIDINS220 Antibody (C-term) western blot analysis in K562 cell line lysates (35ug/lane).This demonstrates the KIDINS220 antibody detected the KIDINS220 protein (arrow).
KIDINS220; ARMS; KIAA1250; Kinase D-interacting substrate of 220 kDa; Ankyrin repeat-rich membrane-spanning protein
Key Feature
Clonality
Polyclonal
Isotype
Ig
Host Species
Rabbit
Tested Applications
WB
WB:1:100~500
Species Reactivity
Human
Concentration
1mg/ml
Target Information
Gene Synonyms
ARMS KIAA1250
Alternative Names
KIDINS220 ARMS KIAA1250 Kinase D-interacting substrate of 220 kDa Ankyrin repeat-rich membrane-spanning protein
Molecular Weight(MW)
196542 Da
Function
Promotes a prolonged MAP-kinase signaling by neurotrophins through activation of a Rap1-dependent mechanism Provides a docking site for the CRKL-C3G complex, resulting in Rap1-dependent sustained ERK activation. May play an important role in regulating postsynaptic signal transduction through the syntrophin-mediated localization of receptor tyrosine kinases such as EPHA4. In cooperation with SNTA1 can enhance EPHA4-induced JAK/STAT activation. May play a role in neurotrophin- and ephrin- mediated neuronal outgrowth and in axon guidance during neural development and in neuronal regeneration (By similarity) Modulates stress-induced apoptosis of melanoma cells via regulation of the MEK/ERK signaling pathway
Tissue Specificity
Abundant in developing and adult neural tissues as well as neuroendocrine cells and dendritic cells Overexpressed in melanoma and melanoma cell lines
KIDINS220 Antibody (C-term) western blot analysis in K562 cell line lysates (35ug/lane).This demonstrates the KIDINS220 antibody detected the KIDINS220 protein (arrow).
Application Notes
WB:1:100~500
Additional Information
Form
Liquid
Storage Instructions
For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Storage Buffer
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.